Q/C Technologies, Inc. Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations
Q/C Technologies, Inc. (QCLS) reported Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations of $269.34 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-04-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems · last filed 2017-04-11
- Q/C Technologies, Inc. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2015 was $269.34K.
| Period end | Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations 12 month |
|---|---|
| 2015-12-31 | $269.34K 10-K · filed 2017-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |